Overview and Scope
3D Bioprinting is a type of additive manufacturing that prints live structures layer by layer, mimicking the behavior of actual living systems, using cells and other biocompatible materials like inks, also known as bio-inks. 3D bioprinting materials are mainly used in connection with drug research and most recently as cell scaffolds to help repair damaged ligaments and joints.
Sizing and Forecast
The 3d bioprinting market size has grown rapidly in recent years. It will grow from <b>$1.59 billion in 2023 to $1.9 billion in 2024 at a compound annual growth rate (CAGR) of 19.8%. </b> The growth in the historic period can be attributed to research and development funding, growth in chronic diseases, organ shortage, rise in pharmaceutical testing, growth in tissue engineering.
The 3d bioprinting market size is expected to see exponential growth in the next few years. It will grow to <b>$4.15 billion in 2028 at a compound annual growth rate (CAGR) of 21.6%. </b> The growth in the forecast period can be attributed to healthcare advancements, rising development of bioprinted skin, growing awareness among patients, aging population . Major trends in the forecast period include multi-material printing, vascularization techniques, organ-on-a-chip, custom implants, biofabrication in space.
To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/3d-bioprinting-global-market-report
Segmentation & Regional Insights
The 3d bioprinting market covered in this report is segmented –
1) By Component: 3D Bioprinters, Bioinks
2) By Material: Living Cells, Hydrogels, Extracellular Matrices, Other Materials
3) By Application: Research Applications, Clinical Application, Other Applications
4) By End User: Research Organization And Academic Institutes, Biopharmaceuticals Companies, Hospitals, Other End Users
<b>North America</b> was the largest region in the 3D bioprinting market in 2023. The <b>Asia-Pacific</b> is expected to be the fastest-growing region in the 3D bioprinting market during the forecast period. The regions covered in the 3d bioprinting market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5341&type=smp
Major Driver Impacting Market Growth
Rising governments and private funding to support 3D bioprinting research activities are expected to drive the growth of the 3D bioprinting market in the forecast period. 3D bioprinting is increasing applications in healthcare attracted funding from government and private organizations. This funding provides financial and technical assistance across different development phases of 3D bioprinting techniques. For instance, in May 2021, Readily3d SA, a Switzerland-based bioprinting company, received funding of $600,000 from the European Union to develop a living miniature model of the pancreas using its Tomolite 3D bioprinting technique. The Australian Minister for Health funded Curtin University with $737,690 in June 2020 to develop and optimize 3D technology for bioprinting skin tissue directly onto model wounds as a prelude to human skin restoration.
Key Industry Players
Major companies operating in the 3d bioprinting market include <b> Organovo Holdings Inc., Allevi Inc., Cellink AB, Aspect Biosystems Ltd., 3D Systems Corporation, Cyfuse Biomedical KK, EnvisionTEC GmbH, Poietis SA, TeVido BioDevices, Nano3D Biosciences Inc., Digilab Inc., RegenHU Ltd., GeSiM mbH, Advanced Solutions Life Sciences LLC, Regenovo Biotechnology Co. Ltd., Regemat 3D S.L., Bio3D Technologies, Stratasys Ltd., ROKIT Healthcare Co. Ltd., Inventia Life Science Pvt. Ltd., Vivax Bio LLC, GE HealthCare Technologies Inc., 3D Biotek LLC, Nuclera Nucleics Ltd., 3D Fortify Inc., Carbon Inc., Divergent Technologies Inc., Markforged Inc., SprintRay Inc., 3D Bio Corp, 3D Bioprinting Solutions, BICO Group AB, CollPlant Biotechnologies Ltd., Shining 3D Tech Co. Ltd., 3Dynamic Systems Ltd., Modern Meadow Inc. </b>
The 3d bioprinting market report table of contents includes:
1. Executive Summary
2.3D Bioprinting Market Characteristics
3.3D Bioprinting Market Trends And Strategies
4.3D Bioprinting Market analysis
5.3D Bioprinting Market Size And Growth
6.3D Bioprinting Segmentation
7.3D Bioprinting Regional And Country Analysis
.
.
.
27.3D Bioprinting Competitive Landscape And Company Profiles
28.3D Bioprinting Key Mergers And Acquisitions
29.3D Bioprinting Future Outlook and Potential Analysis
TOP MAJOR PLAYERS:
- Organovo Holdings Inc.
- Allevi Inc.
- Cellink AB
- Aspect Biosystems Ltd.
- 3D Systems Corporation
- Cyfuse Biomedical KK
Explore the trending research reports from TBRC:
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
